Immune reconstitution inflammatory syndrome (IRIS) as a cause for inhibitor development in hemophilia [2]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 193-194

  Werwitzke, Sonja ^a   Tiede, A ^a   Stoll, M ^a   Von Depka, M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; CD20 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LAMIVUDINE; NELFINAVIR; NEUTRALIZING ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 8; ZIDOVUDINE; RECOMBINANT PROTEIN;

ADULT; ANTIBODY TITER; B LYMPHOCYTE; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CASE REPORT; HEMOPHILIA A; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; LETTER; MALE; NONSENSE MUTATION; PRIORITY JOURNAL; STOP CODON; T LYMPHOCYTE; DRUG ANTAGONISM; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; SYNDROME;

FACTOR VIII; HEMOPHILIA A; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SYNDROME;

EID: 4344641793     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.0562b.x     Document Type: Letter

References (6)

1. Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, Gungor T, Krackhardt B, Kornhuber B. Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
2. Bray GL, Kroner BL, Arkin S, Aledort LW, Hilgartner MW, Eyster ME, Ragni MV, Goedert JJ. Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study. Am J Hematol 1993; 42: 375-9.
3. Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, Japour AJ. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252-5.
4. Stoll M, Schmidt RE. Immune restoration inflammatory syndromes: the dark side of successful antiretroviral treatment. Curr Infect Dis Rep 2003; 5: 266-76.
5. Gilquin J, Viard JP, Jubault V, Sert C, Kazatchkine MD. Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet 1998; 352 1907-8.
6. Behrens G, Knuth C, Schedel I, Mendila M, Schmidt RE. Highly active antiretroviral therapy. Lancet 1998; 351: 1057-8.